Banmeet Anand
Corporate Officer/Principal bei HARPOON THERAPEUTICS, INC.
Aktive Positionen von Banmeet Anand
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 06.07.2022 | - |
Karriereverlauf von Banmeet Anand
Ehemalige bekannte Positionen von Banmeet Anand
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MOLECULAR TEMPLATES, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Banmeet Anand
| University of Missouri | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Banmeet Anand
- Erfahrung